Complete Genomics seals $45M for cheaper gene sequencing

Complete Genomics seals $45M for cheaper gene sequencing

Complete Genomics, provider of supposedly cheaper and faster DNA sequencing services, has raised $45 million in a fourth round of funding — a huge amount for a biotech company in today’s economic environment. Based in Mountain View, Calif., the company says it will be able… Continue Reading

The genomic frontier: Personalized medicine in action

The genomic frontier: Personalized medicine in action

[Editor's note: As we've reported, the economic downturn and frozen IPO market have been especially tough on health care companies. But that doesn't mean innovation has slowed across the board. Below, Clifford Reid, chief executive of genome sequencing company Complete Genomics, discusses the financial concerns... Continue Reading

Complete Genomics and BioNanomatrix rev up the fast, cheap and out-of-control genome race

Complete Genomics and BioNanomatrix rev up the fast, cheap and out-of-control genome race

Things are starting to get crowded in the race to sequence entire human genomes quickly and relatively cheaply — usually meaning somewhere in the territory of $1,000 per genome, compared to the $100,000+ it costs with current technology. At least four startups have taken on… Continue Reading

Complete Genomics raises second round for high-speed sequencing

See our story on this Mountain View, Calif., biotech in today’s daily briefing at VentureBeat Life Sciences.

Life sciences briefing: Friday, Sept. 21, 2007

Life sciences briefing: Friday, Sept. 21, 2007

Featured companies: CG Therapeutics, Complete Genomics, ConforMIS, Flexible Medical Systems, LeMaitre Vascular, MAP Pharmaceuticals, ParaPro, Vascular Architects, Zars Pharma

(UPDATED on 10/1/07: See below.)

[NOTE: Posting has been slow recently for personal reasons. I'll be doing my best to catch up today.]

Complete Genomics raises funding for high-speed sequencing —… Continue Reading